Skip to main content

Caxton Corp

SEC CIK
0001388551
Latest filing
Aug 13, 2026

Holdings in Q1 2022

Holdings as of Mar 31, 2022, filed May 16, 2022. Long positions only; changes compare share counts with Q4 2021.

Institution overview
Positions
37
−15 vs. Q4 2021
Portfolio value
$80.4M
−$41.9M (−34.3%) vs. Q4 2021
Filed
May 16, 2022
SEC
Holdings of Caxton Corp in Q1 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
XERSXeris Biopharma Holdings, Inc.COM6,039,028$15.5M19.2%−271,518−4.3%ReducedHistory
SVRASavara IncCOM6,896,551$9.03M11.2%−20,000−0.3%ReducedHistory
GLDSPDR Gold TrustETF40,820$7.37M9.2%00.0%UnchangedHistory
SPYSPDR S&P 500 ETF TrustETF15,947$7.20M9.0%+8,967+128.5%AddedHistory
MTEMMolecular Templates, Inc.COM2,052,991$7.08M8.8%−85,000−4.0%ReducedHistory
SCYXScynexis IncCOM NEW1,723,947$6.74M8.4%−24,839−1.4%ReducedHistory
Pershing Square Tontine Hldg71531R109COM CL A227,000$4.51M5.6%00.0%Unchanged–
RZLTRezolute, Inc.COM NEW1,193,473$4.03M5.0%00.0%UnchangedHistory
ADXNAddex Therapeutics Ltd.SPONSORED ADS265,940$1.35M1.7%00.0%UnchangedHistory
ACLXArcellx, Inc.COMMON STOCK88,820$1.25M1.5%+88,820NewHistory
GOOGAlphabet Inc.Stock395$1.10M1.4%−4−1.0%ReducedHistory
MSFTMicrosoft CorpStock3,263$1.01M1.3%−36−1.1%ReducedHistory
EIGREiger BioPharmaceuticals, Inc.COM116,884$970.0K1.2%00.0%UnchangedHistory
INTUIntuit Inc.Stock1,965$945.0K1.2%−24−1.2%ReducedHistory
SPGIS&P Global Inc.Stock2,225$912.0K1.1%−26−1.2%ReducedHistory
TDGTransDigm Group INCCOM1,391$906.0K1.1%−16−1.1%ReducedHistory
VVisa Inc.Stock3,931$872.0K1.1%−50−1.3%ReducedHistory
MAMastercard IncStock2,438$871.0K1.1%−31−1.3%ReducedHistory
MCOMoodys CorpStock2,567$866.0K1.1%−33−1.3%ReducedHistory
MDLZMondelez International, Inc.Stock13,405$842.0K1.0%−177−1.3%ReducedHistory
AMTAmerican Tower CorpREIT3,196$803.0K1.0%−44−1.4%ReducedHistory
FICOFair Isaac CorpCOM1,715$800.0K1.0%−24−1.4%ReducedHistory
CRMSalesforce, Inc.Stock3,294$699.0K0.9%−52−1.6%ReducedHistory
DISWalt Disney CoStock5,002$686.0K0.9%−80−1.6%ReducedHistory
WHRWhirlpool CorpStock3,843$664.0K0.8%−63−1.6%ReducedHistory
CHTRCharter Communications, Inc.CL A1,210$660.0K0.8%−20−1.6%ReducedHistory
METAMeta Platforms, Inc.Stock2,791$621.0K0.8%−49−1.7%ReducedHistory
NFLXNetflix IncStock1,484$556.0K0.7%−29−1.9%ReducedHistory
CDLXCardlytics, Inc.COM8,543$470.0K0.6%−197−2.3%ReducedHistory
PYPLPayPal Holdings, Inc.Stock3,538$409.0K0.5%−95−2.6%ReducedHistory
CVNACarvana Co.CL A3,224$385.0K0.5%−92−2.8%ReducedHistory
ELEVElevation Acquisition Group Inc.COM68,279$172.0K0.2%+12,980+23.5%AddedHistory
RMG Acquisition Corp IIIG76088114UNIT 02/08/202611,000$109.0K0.1%00.0%Unchanged–
Lux Health Tech Acquisition55068A118*W EXP 11/30/20266,666$28.0K<0.1%00.0%Unchanged–
Bridgetown Holdings LtdG1355U121*W EXP 09/30/20239,773$23.0K<0.1%00.0%Unchanged–
Primavera Capital Acquist CoG7255E117*W EXP 01/19/20212,000$5.00K<0.1%00.0%Unchanged–
Frazier Lifesciences Acqu CoG3710A113*W EXP 11/30/20221,333$4.00K<0.1%00.0%Unchanged–

Sold out since Q4 2021 (16)

Positions held at the end of Q4 2021 that are gone from this filing.

Positions of Caxton Corp sold out since Q4 2021
SecurityClassShares in Q4 2021Value in Q4 2021% of portfolio in Q4 2021History
CRDFCardiff Oncology, Inc.COM2,522,083$15.2M12.4%History
SRRASierra Oncology, Inc.COM NEW262,969$5.72M4.7%History
CTICCti Biopharma CorpCOM2,239,300$5.55M4.5%History
Lux Health Tech Acquisition55068A100COM CL A200,000$1.96M1.6%–
iShares MSCI Eafe ETF464287465ETF19,000$1.50M1.2%–
Ares Acquisition CorporationG33032114UNIT 99/99/9999139,680$1.39M1.1%–
FLACFrazier Lifesciences Acquisition CorpCL A SHS64,000$624.0K0.5%History
Bridgetown Holdings LtdG1355U113COM CL A62,688$616.0K0.5%–
Science Strategic Acq Alpha808641203UNIT 01/20/202662,000$613.0K0.5%–
HumanCo Acquisition Corp.44487N208UNIT 12/08/202357,724$585.0K0.5%–
SVF Investment Corp.G8601L102CL A SHS27,900$280.0K0.2%–
Primavera Capital Acquist CoG7255E109SHS CL A24,000$233.0K0.2%–
ScION Tech Growth IG31067120UNIT 12/17/202522,410$223.0K0.2%–
Pivotal Investment Corp III72582M205UNIT 01/28/202816,800$166.0K0.1%–
MLTXMoonLake ImmunotherapeuticsCOM CL A16,009$158.0K0.1%History
KALAKALA BIO, Inc.COM13,155$16.0K<0.1%History